Business Units or Product Lines

Perrigo operates through two primary business segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). CSCA focuses on over-the-counter healthcare products, infant formula, and oral self-care in the Americas, while CSCI includes similar products targeted at the European and other international markets.

Business Models for Each Product Line

Perrigo's CSCA and CSCI segments generate revenue primarily through the sale of consumer self-care, over-the-counter, and wellness products. Key revenue streams include retail partnerships, direct-to-consumer sales, and licensing arrangements. Major expenses include manufacturing, marketing, R&D, and distribution costs.

Future Opportunities for Growth

Growth opportunities for Perrigo include expanding into emerging markets, enhancing e-commerce capabilities, increasing market penetration for existing products, and developing new products in the wellness and self-care categories. Strategic acquisitions to broaden product offerings also present growth potential.

Potential Major Risks

Major risks to Perrigo include regulatory changes affecting product approvals, intense competition in the self-care and over-the-counter markets, potential manufacturing disruptions, and currency fluctuations impacting international sales. Additionally, economic downturns could impact consumer spending on healthcare products.